PFA Delivered with a Difference
Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
The challenge
Despite advancements in cardiac ablation technology, long-term success remains underwhelming, between 40%–80% depending on number of procedures and the patient population. [Ganesan AN et al. Long-term outcomes of catheter ablation of atrial fibrillation: A systematic review and meta-analysis. JAHA 2013]
Radiofrequency (RF) and Cryothermy (Cryo) are the most used ablation energy sources to treat AFib, atrial flutter and all other heart arrhythmias.
- RF and Cryo are thermal energy sources using heat or cold, respectively, to destroy heart tissue responsible for the arrhythmia.
- Thermal energy delivery can be difficult to control, indiscriminately destroying tissue and increasing the risk of collateral injuries, such as esophageal fistulas, pulmonary vein stenosis, and phrenic nerve palsy. [Reddy V et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023;DOI:10.1056/NEJMoa2307291]
Patients require a treatment option that is safer, faster and more effective. It requires a solution that can improve long-term outcomes.
Argá MEDTECH'S solution
Argá Medtech is developing a next generation, non-thermal, cardiac ablation system. Our unique Pulsed Field Ablation (PFA) System offers unmatched versatility when used with its proprietary catheter.
